Table 2.

Unadjusted and adjusted Cox proportional hazard analysis for overall survival

Overall survival
	Unadjusted model Overall cohort			Large adjusted model Overall cohort			Simple adjusted model Overall cohort
	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p
MCT1	1.622	1.030–2.554	0.037	2.123	1.145–3.937	0.017	1.963	1.199–3.214	0.007
Grade	4.684	1.715–12.79	0.003	3.210	1.136–9.076	0.028	3.797	1.372–10.50	0.010
Stage	2.288	1.500–3.489	<0.001	1.965	1.078–3.579	0.027	2.080	1.300–3.328	0.002
Size	1.269	0.585–2.750	0.547	0.681	0.306–1.515	0.346	–	–	–
LVSI	2.347	0.935–5.891	0.069	1.185	0.378–3.718	0.771	–	–	–
MI	1.447	0.609–3.436	0.403	1.121	0.340–3.690	0.851	–	–	–

Grade categorised as Grade I/II and III tumours; Stage: FIGO 2009 stage categorised as 1, 2, 3 and 4; Size categorised as <2 cm, between 2 and 5 cm and bigger than 5 cm; LVSI: Lymphovascular space involvement categorised as “Yes” and “No”; MI: Depth of myometrial invasion categorised as <50% and more than 50%; HR: hazard ratio, CI: confidence interval. Bold text indicates statistically significant data at p < 0.05 level